Associate Director
Companion Diagnostics
Posted on 3/22/2024
Revolution Medicines

201-500 employees

Develops targeted therapies for RAS-addicted cancers.
Company Overview
REVOLUTION Medicines stands out in the oncology field for its unique approach to drug discovery, leveraging insights from nature and evolution to develop targeted therapies for RAS-addicted cancers. The company's robust drug discovery and medicinal chemistry capabilities have resulted in a deep pipeline of RAS inhibitors, with their most advanced product, RMC-4630, currently in a multi-cohort Phase 1/2 clinical program. This focus on genetic drivers and adaptive resistance mechanisms in cancer, coupled with their commitment to exploring mechanism-based dosing paradigms and in-pathway combinations, positions REVOLUTION Medicines as a leader in precision oncology.
Biotechnology

Company Stage

N/A

Total Funding

$1.3B

Founded

2014

Headquarters

Redwood City, California

Growth & Insights
Headcount

6 month growth

19%

1 year growth

54%

2 year growth

92%
Locations
San Carlos, CA, USA
Experience Level
Entry
Junior
Mid
Senior
Expert
CategoriesNew
Genomics
Biology Lab & Research
Biology & Biotech
Requirements
  • Ph.D. in cancer biology, cell/molecular biology, genomics or equivalent with 6+ years of industry experience
  • 2+ years of experience in CDx development
  • Broad knowledge and understanding of established and novel technologies employed in clinical diagnostic assays (e.g. NGS, IHC, PCR)
  • Excellent scientific and business communication skills
  • Strong interpersonal/collaboration skills and planning skills
  • Ability to think critically and creatively and be able to work independently
  • Ability to multi-task and thrive in a fast-paced innovative environment
  • Commitment to Revolution Medicines’ Core Values
Responsibilities
  • Drive implementation of the CDx strategy to support early and late-stage development of portfolio assets
  • Lead or participate in joint project teams (JPTs) with diagnostic partners and internal cross-functional team members
  • Effectively collaborate with biomarker scientists, biomarker operations, clinical development, and clinical operations
  • Collaborate closely with diagnostic partners and internal functions
  • Manage contracts, budgets, and timelines of key milestones associated with CDx development
  • Develop plans for publication of CDx test results in identifying biomarker-positive patient populations
  • Develop strategies that enable access to CDx tests for launch readiness